Inhibition of the formation of tetrahydroisoquinoline alkaloids in brain homogenates.
D000470:Alkaloids / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000302:isolation & purification; D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D002247:Carbon Isotopes; D002854:Chromatography, Paper; D002855:Chromatography, Thin Layer; D003545:Cysteine / Q000494:pharmacology; D003864:Depression, Chemical; D004298:Dopamine / Q000032:analysis; D005978:Glutathione / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D008995:Monoamine Oxidase / Q000032:analysis; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D013056:Spectrophotometry, Ultraviolet
D000470:Alkaloids; D002247:Carbon Isotopes; D007546:Isoquinolines; D010293:Pargyline; D008995:Monoamine Oxidase; D005978:Glutathione; D003545:Cysteine; D001205:Ascorbic Acid; D004298:Dopamine